Literature DB >> 6416537

Amiodarone: the experience of the past decade.

W J McKenna, E Rowland, D M Krikler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6416537      PMCID: PMC1550155          DOI: 10.1136/bmj.287.6406.1654

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  29 in total

1.  The adrenergic antagonism of amiodarone.

Authors:  P Polster; J Broekhuysen
Journal:  Biochem Pharmacol       Date:  1976-01-15       Impact factor: 5.858

2.  Arrhythmia in hypertrophic cardiomyopathy. II: Comparison of amiodarone and verapamil in treatment.

Authors:  W J McKenna; L Harris; G Perez; D M Krikler; C Oakley; J F Goodwin
Journal:  Br Heart J       Date:  1981-08

3.  Pulmonary fibrosis--a serious side-effect of amiodarone therapy.

Authors:  A A Quyyumi; L P Ormerod; S W Clarke; T R Evans; R L Ward
Journal:  Eur Heart J       Date:  1983-07       Impact factor: 29.983

4.  Amiodarone increases plasma digoxin concentrations.

Authors:  J O Moysey; N S Jaggarao; E N Grundy; D A Chamberlain
Journal:  Br Med J (Clin Res Ed)       Date:  1981-01-24

Review 5.  Clinical pharmacology and therapeutic applications of the antiarrhythmic agent amiodarone.

Authors:  F I Marcus; G H Fontaine; R Frank; Y Grosgogeat
Journal:  Am Heart J       Date:  1981-04       Impact factor: 4.749

6.  Control of refractory life-threatening ventricular tachyarrhythmias by amiodarone.

Authors:  K Nademanee; J A Hendrickson; D S Cannom; B N Goldreyer; B N Singh
Journal:  Am Heart J       Date:  1981-06       Impact factor: 4.749

7.  [Amiodaron neuropathy: clinical and pathological study of a new drug induced lipidosis (author's transl)].

Authors:  P Dudognon; J J Hauw; C de Baecque; J P Derrida; R Escourolle; E J Nick
Journal:  Rev Neurol (Paris)       Date:  1979 Jul-Aug       Impact factor: 2.607

8.  Amiodarone keratopathy: drug-induced lipid storage disease.

Authors:  D J D'Amico; K R Kenyon; J N Ruskin
Journal:  Arch Ophthalmol       Date:  1981-02

9.  Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation.

Authors:  J J Heger; E N Prystowsky; W M Jackman; G V Naccarelli; K A Warfel; R L Rinkenberger; D P Zipes
Journal:  N Engl J Med       Date:  1981-09-03       Impact factor: 91.245

10.  ["Torsades de pointe" and reentry induced by anti-arrhythmia agents].

Authors:  M Brochier; J P Fauchier
Journal:  Arch Mal Coeur Vaiss       Date:  1978-04
View more
  7 in total

1.  Segmental pulmonary consolidation due to amiodarone.

Authors:  P Gibb; L J Melendez
Journal:  CMAJ       Date:  1986-03-15       Impact factor: 8.262

2.  Clinical evaluation of the efficacy of oral amiodarone.

Authors:  W J McKenna; D M Krikler
Journal:  Br Heart J       Date:  1984-03

3.  Drug and non-thyroid induced changes in thyroid function tests.

Authors:  I Ramsay
Journal:  Postgrad Med J       Date:  1985-05       Impact factor: 2.401

4.  Effects of amiodarone and thyroid dysfunction on myocardial calcium, serum calcium and thyroid hormones in the rat.

Authors:  M D Gammage; J A Franklyn; S D Logan
Journal:  Br J Pharmacol       Date:  1987-10       Impact factor: 8.739

5.  Clinical, haemodynamic, and antiarrhythmic effects of long term treatment with amiodarone of patients in heart failure.

Authors:  J G Cleland; H J Dargie; I N Findlay; J T Wilson
Journal:  Br Heart J       Date:  1987-05

6.  Amiodarone reduces plasma warfarin clearance in man.

Authors:  A H Watt; M R Stephens; D C Buss; P A Routledge
Journal:  Br J Clin Pharmacol       Date:  1985-12       Impact factor: 4.335

Review 7.  Cutaneous adverse reactions of amiodarone.

Authors:  Krzysztof Jaworski; Irena Walecka; Lidia Rudnicka; Maciej Gnatowski; Dariusz A Kosior
Journal:  Med Sci Monit       Date:  2014-11-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.